Blythe Sather

Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease

Blythe Sather, Piper Treuting, Nikole Perdue et al. · The Journal of Experimental Medicine · 2007 · 398 citations · Full text

GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells

Eric L. Smith, Kim Harrington, Reed Masakayan et al. · Science Translational Medicine · 2019 · 373 citations · Full text

Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells

Daniela A. Bermejo, Shaun W. Jackson, Melisa Gorosito-Serrán et al. · Nature Immunology · 2013 · 238 citations · Full text

Activated B Cells, African Trypanosomiasis, Il-17 Production +11

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

Ryan M. Teague, Blythe Sather, Jilian A. Sacks et al. · Nature Medicine · 2006 · 231 citations

Cell Therapy, Tumor Immunology, Cancer Immunosurveillance +12

Efficient modification of <i>CCR5</i> in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template

Blythe Sather, Guillermo S. Romano Ibarra, Karen Sommer et al. · Science Translational Medicine · 2015 · 226 citations · Full text